NCT06459310View on ClinicalTrials.gov

Pilot Study on Evaluating the Geroprotective Effect of Metformin

PHASE2RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

July 31, 2028

Conditions
MetforminAging
Interventions
DRUG

Metformin Hydrochloride tablet

Extended release oral tablets, 1000 mg/day, single dose

DRUG

Placebo

Oral tablets, 1000 mg/day, single dose

Trial Locations (1)

Unknown

RECRUITING

Xuanwu Hospital Capital Medical University, Beijing

All Listed Sponsors
collaborator

Institute of Zoology, Chinese Academy of Sciences

OTHER_GOV

collaborator

Beijing Institute of Genomics, Chinese Academy of Sciences

OTHER_GOV

collaborator

Merck Serono Co., Ltd., China

INDUSTRY

lead

Xuanwu Hospital, Beijing

OTHER